2-(3,4-dimethoxylphenylamino)ethanol

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(3,4-dimethoxylphenylamino)ethanol
• 英文别名: 2-(3,4-Dimethoxyanilino)ethanol
• 化学式: C₁₀H₁₅NO₃
• 分子量: 197.234
• InChiKey: UGYZPQIOOCDCAI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  50.7
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-羟乙酰乙酸内酯 、 2-(3,4-dimethoxylphenylamino)ethanol 、 3-氯苯甲醛 以 乙醇 为溶剂， 以72%的产率得到9-(3-chlorophenyl)-4-(2-hydroxyethyl)-6,7-dimethoxy-4,9-dihydrofuro[3,4-b]quinolin-1(3H)-one
  参考文献：
  名称：

  Identification of the First Inhibitor of the GBP1:PIM1 Interaction. Implications for the Development of a New Class of Anticancer Agents against Paclitaxel Resistant Cancer Cells

  摘要：

  Class III beta-tubulin plays a prominent role in the development of drug resistance to paclitaxel by allowing the incorporation of the GBP1 GTPase into microtubules. Once in the cytoskeleton. GBP1 binds to prosurvival kinases such as PIM1 and initiates a signaling pathway that induces resistance to paclitaxel. Therefore, the inhibition of the GBP1:PIM1 interaction could potentially revert resistance to paclitaxel. A panel of 44 4-azapodophyllotoxin. derivatives was screened in the NCI-60 cell panel. The result is that 31 are active and the comparative analysis demonstrated specific activity in paclitax el-resistant cells, Using surface plasmon resonance, we were able to prove that NSC756093 is a potent in vitro inhibitor of the GBP1:PIM1 interaction and that this property is maintained in vivo in ovarian cancer cells resistant to paclitaxel. Through bioinformatics, molecular modeling and mutagenesis studies, we identified the putative NSC756093 binding site at the interface between the helical and the LG domain of GBP1. According to our results by binding to this site the NSC756093 compound is able to stabilize a conformation of GBP1 not suitable for binding to PIM1.

  DOI：

  10.1021/jm5009902
• 作为产物：
  描述：

  3,4-二甲氧基苯胺 在 吡啶 、 乙醇 、 potassium hydroxide 作用下， 以 二氯甲烷 为溶剂， 生成 2-(3,4-dimethoxylphenylamino)ethanol
  参考文献：
  名称：

  Identification of the First Inhibitor of the GBP1:PIM1 Interaction. Implications for the Development of a New Class of Anticancer Agents against Paclitaxel Resistant Cancer Cells

  摘要：

  Class III beta-tubulin plays a prominent role in the development of drug resistance to paclitaxel by allowing the incorporation of the GBP1 GTPase into microtubules. Once in the cytoskeleton. GBP1 binds to prosurvival kinases such as PIM1 and initiates a signaling pathway that induces resistance to paclitaxel. Therefore, the inhibition of the GBP1:PIM1 interaction could potentially revert resistance to paclitaxel. A panel of 44 4-azapodophyllotoxin. derivatives was screened in the NCI-60 cell panel. The result is that 31 are active and the comparative analysis demonstrated specific activity in paclitax el-resistant cells, Using surface plasmon resonance, we were able to prove that NSC756093 is a potent in vitro inhibitor of the GBP1:PIM1 interaction and that this property is maintained in vivo in ovarian cancer cells resistant to paclitaxel. Through bioinformatics, molecular modeling and mutagenesis studies, we identified the putative NSC756093 binding site at the interface between the helical and the LG domain of GBP1. According to our results by binding to this site the NSC756093 compound is able to stabilize a conformation of GBP1 not suitable for binding to PIM1.

  DOI：

  10.1021/jm5009902

文献信息

• β-Amino alcohols from anilines and ethylene glycol through heterogeneous Borrowing Hydrogen reaction
  作者：Pedro J. Llabres-Campaner、Rafael Ballesteros-Garrido、Rafael Ballesteros、Belén Abarca

  DOI：10.1016/j.tet.2017.08.006

  日期：2017.9

  Borrowing Hydrogen (BH), also called Hydrogen Autotransfer (HA), reaction with neat ethylene glycol represents a key step in the preparation of β-amino alcohols. However, due to the stability of ethylene glycol, mono-activation has rarely been achieved. Herein, a combination of Pd/C and ZnO is reported as heterogeneous catalyst for this BH/HA reaction. This system results in an extremely air and moisture

  与纯乙二醇的借入氢（BH）也称为氢自动转移（HA），是制备β-氨基醇的关键步骤。然而，由于乙二醇的稳定性，很少实现单活化。在此，据报道Pd / C和ZnO的组合作为该BH / HA反应的非均相催化剂。该系统产生了极好的空气和湿气稳定性，并且经济的催化剂能够将水中的乙二醇单官能化，而无需进一步活化二醇。在这项工作中，已经探索了不同的二醇和芳族胺，为氨基醇的开发提供了一种新方法。这项研究揭示了两种固体物质的组合如何在异相中提供有趣的催化性能。ZnO激活乙二醇，而Pd / C则负责BH / HA循环。重新芳香化之前的原位BH / HA循环，代表串联异质过程。
• [EN] INHIBITORS OF HISTONE DEACETYLASE<br/>[FR] INHIBITEURS DE L'HISTONE-DEACETYLASE
  申请人：METHYLGENE INC

  公开号：WO2003024448A2

  公开（公告）日：2003-03-27

  The invention relates to the inhibition of histone deacetylase. The invention provides compounds e.g. (1) and methods for inhibiting deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions. (formula 1). All definitions are as the application.
• Identification of the First Inhibitor of the GBP1:PIM1 Interaction. Implications for the Development of a New Class of Anticancer Agents against Paclitaxel Resistant Cancer Cells
  作者：Mirko Andreoli、Marco Persico、Ajay Kumar、Nausicaa Orteca、Vineet Kumar、Antonella Pepe、Sakkarapalayam Mahalingam、Antonio E. Alegria、Lella Petrella、Laima Sevciunaite、Alessia Camperchioli、Marisa Mariani、Antonio Di Dato、Ettore Novellino、Giovanni Scambia、Sanjay V. Malhotra、Cristiano Ferlini、Caterina Fattorusso

  DOI：10.1021/jm5009902

  日期：2014.10.9

  Class III beta-tubulin plays a prominent role in the development of drug resistance to paclitaxel by allowing the incorporation of the GBP1 GTPase into microtubules. Once in the cytoskeleton. GBP1 binds to prosurvival kinases such as PIM1 and initiates a signaling pathway that induces resistance to paclitaxel. Therefore, the inhibition of the GBP1:PIM1 interaction could potentially revert resistance to paclitaxel. A panel of 44 4-azapodophyllotoxin. derivatives was screened in the NCI-60 cell panel. The result is that 31 are active and the comparative analysis demonstrated specific activity in paclitax el-resistant cells, Using surface plasmon resonance, we were able to prove that NSC756093 is a potent in vitro inhibitor of the GBP1:PIM1 interaction and that this property is maintained in vivo in ovarian cancer cells resistant to paclitaxel. Through bioinformatics, molecular modeling and mutagenesis studies, we identified the putative NSC756093 binding site at the interface between the helical and the LG domain of GBP1. According to our results by binding to this site the NSC756093 compound is able to stabilize a conformation of GBP1 not suitable for binding to PIM1.